This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McDermott, M R Articles by Bienenstock, J Search for Related Content PubMed PubMed Citation Articles by McDermott, M R Articles by Bienenstock, J

 Previous Article  |  Next Article 

J Virol. 1984 September; 51(3): 747-753

Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2.

ABSTRACT

Herpes simplex virus type 2 is a common human venereal pathogen which causes lethal neurological illness after intravaginal inoculation into BALB/cJ mice. To investigate whether an attenuated, nonlethal strain of this virus would confer immunity after inoculation of mice, we constructed a strain containing a partial deletion of the thymidine kinase gene, which is necessary for viral replication and spread in sensory ganglia. Unlike its wild-type counterpart, this deletion-containing strain of herpes simplex virus type 2 caused mild clinical disease and was not lethal when studied in an age-dependent murine model of intravaginal infection. Furthermore, after intravaginal infection, the deletion-containing strain could not be isolated from sensory ganglia at a time when wild-type virus was abundant. Of greater significance, intravaginal inoculation with the deletion-containing strain rendered mice completely resistant to rechallenge with a 10-fold 50% lethal dose of wild-type virus. These results suggest that a strain of herpes simplex virus type 2 containing a deletion of the thymidine kinase gene will be useful in studying the cellular basis of mucosal immunity in the genital tract.

This article has been cited by other articles:

• Johnson, A. J., Chu, C.-F., Milligan, G. N. (2008). Effector CD4+ T-Cell Involvement in Clearance of Infectious Herpes Simplex Virus Type 1 from Sensory Ganglia and Spinal Cords. J. Virol. 82: 9678-9688 [Abstract] [Full Text]  
• Echchannaoui, H., Bianchi, M., Baud, D., Bobst, M., Stehle, J.-C., Nardelli-Haefliger, D. (2008). Intravaginal Immunization of Mice with Recombinant Salmonella enterica Serovar Typhimurium Expressing Human Papillomavirus Type 16 Antigens as a Potential Route of Vaccination against Cervical Cancer. Infect. Immun. 76: 1940-1951 [Abstract] [Full Text]  
• Bird, M. D., Chu, C.-F., Johnson, A. J., Milligan, G. N. (2007). Early Resolution of Herpes Simplex Virus Type 2 Infection of the Murine Genital Tract Involves Stimulation of Genital Parenchymal Cells by Gamma Interferon. J. Virol. 81: 423-426 [Abstract] [Full Text]  
• Gill, N., Deacon, P. M., Lichty, B., Mossman, K. L., Ashkar, A. A. (2006). Induction of Innate Immunity against Herpes Simplex Virus Type 2 Infection via Local Delivery of Toll-Like Receptor Ligands Correlates with Beta Interferon Production.. J. Virol. 80: 9943-9950 [Abstract] [Full Text]  
• Natuk, R. J., Cooper, D., Guo, M., Calderon, P., Wright, K. J., Nasar, F., Witko, S., Pawlyk, D., Lee, M., DeStefano, J., Tummolo, D., Abramovitz, A. S., Gangolli, S., Kalyan, N., Clarke, D. K., Hendry, R. M., Eldridge, J. H., Udem, S. A., Kowalski, J. (2006). Recombinant Vesicular Stomatitis Virus Vectors Expressing Herpes Simplex Virus Type 2 gD Elicit Robust CD4+ Th1 Immune Responses and Are Protective in Mouse and Guinea Pig Models of Vaginal Challenge. J. Virol. 80: 4447-4457 [Abstract] [Full Text]  
• Dobbs, M. E., Strasser, J. E., Chu, C.-F., Chalk, C., Milligan, G. N. (2005). Clearance of Herpes Simplex Virus Type 2 by CD8+ T Cells Requires Gamma Interferon and either Perforin- or Fas-Mediated Cytolytic Mechanisms. J. Virol. 79: 14546-14554 [Abstract] [Full Text]  
• Svensson, A., Kaim, J., Mallard, C., Olsson, A., Brodin, E., Hokfelt, T., Eriksson, K. (2005). Neurokinin 1 Receptor Signaling Affects the Local Innate Immune Defense against Genital Herpes Virus Infection. J. Immunol. 175: 6802-6811 [Abstract] [Full Text]  
• Milligan, G. N., Meador, M. G., Chu, C.-F., Young, C. G., Martin, T. L., Bourne, N. (2005). Long-Term Presence of Virus-Specific Plasma Cells in Sensory Ganglia and Spinal Cord following Intravaginal Inoculation of Herpes Simplex Virus Type 2. J. Virol. 79: 11537-11540 [Abstract] [Full Text]  
• Svensson, A., Nordstrom, I., Sun, J.-B., Eriksson, K. (2005). Protective Immunity to Genital Herpes Simpex Virus Type 2 Infection Is Mediated by T-bet. J. Immunol. 174: 6266-6273 [Abstract] [Full Text]  
• Gill, N., Rosenthal, K. L., Ashkar, A. A. (2005). NK and NKT Cell-Independent Contribution of Interleukin-15 to Innate Protection against Mucosal Viral Infection. J. Virol. 79: 4470-4478 [Abstract] [Full Text]  
• Gillgrass, A. E., Tang, V. A., Towarnicki, K. M., Rosenthal, K. L., Kaushic, C. (2005). Protection against Genital Herpes Infection in Mice Immunized under Different Hormonal Conditions Correlates with Induction of Vagina-Associated Lymphoid Tissue. J. Virol. 79: 3117-3126 [Abstract] [Full Text]  
• Aurelian, L. (2004). Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism?. CVI 11: 437-445 [Abstract] [Full Text]  
• Gillgrass, A. E., Ashkar, A. A., Rosenthal, K. L., Kaushic, C. (2003). Prolonged Exposure to Progesterone Prevents Induction of Protective Mucosal Responses following Intravaginal Immunization with Attenuated Herpes Simplex Virus Type 2. J. Virol. 77: 9845-9851 [Abstract] [Full Text]  
• Murphy, J. A., Duerst, R. J., Smith, T. J., Morrison, L. A. (2003). Herpes Simplex Virus Type 2 Virion Host Shutoff Protein Regulates Alpha/Beta Interferon but Not Adaptive Immune Responses during Primary Infection In Vivo. J. Virol. 77: 9337-9345 [Abstract] [Full Text]  
• Ashkar, A. A., Bauer, S., Mitchell, W. J., Vieira, J., Rosenthal, K. L. (2003). Local Delivery of CpG Oligodeoxynucleotides Induces Rapid Changes in the Genital Mucosa and Inhibits Replication, but Not Entry, of Herpes Simplex Virus Type 2. J. Virol. 77: 8948-8956 [Abstract] [Full Text]  
• Zhao, X., Deak, E., Soderberg, K., Linehan, M., Spezzano, D., Zhu, J., Knipe, D. M., Iwasaki, A. (2003). Vaginal Submucosal Dendritic Cells, but Not Langerhans Cells, Induce Protective Th1 Responses to Herpes Simplex Virus-2. J. Exp. Med. 197: 153-162 [Abstract] [Full Text]  
• Harandi, A. M., Svennerholm, B., Holmgren, J., Eriksson, K. (2001). Interleukin-12 (IL-12) and IL-18 Are Important in Innate Defense against Genital Herpes Simplex Virus Type 2 Infection in Mice but Are Not Required for the Development of Acquired Gamma Interferon-Mediated Protective Immunity. J. Virol. 75: 6705-6709 [Abstract] [Full Text]  
• Harandi, A. M., Svennerholm, B., Holmgren, J., Eriksson, K. (2001). Differential roles of B cells and IFN-{{gamma}}-secreting CD4+ T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J. Gen. Virol. 82: 845-853 [Abstract] [Full Text]  
• Morrison, L. A., Zhu, L., Thebeau, L. G. (2001). Vaccine-Induced Serum Immunoglobin Contributes to Protection from Herpes Simplex Virus Type 2 Genital Infection in the Presence of Immune T Cells. J. Virol. 75: 1195-1204 [Abstract] [Full Text]  
• Harle, P., Noisakran, S., Carr, D. J. J. (2001). The Application of a Plasmid DNA Encoding IFN-{{alpha}}1 Postinfection Enhances Cumulative Survival of Herpes Simplex Virus Type 2 Vaginally Infected Mice. J. Immunol. 166: 1803-1812 [Abstract] [Full Text]  
• Sin, J.-I., Kim, J. J., Pachuk, C., Satishchandran, C., Weiner, D. B. (2000). DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo. J. Virol. 74: 11173-11180 [Abstract] [Full Text]  
• Milligan, G. N. (1999). Neutrophils Aid in Protection of the Vaginal Mucosae of Immune Mice against Challenge with Herpes Simplex Virus Type 2. J. Virol. 73: 6380-6386 [Abstract] [Full Text]  
• Sin, J.-I., Kim, J. J., Boyer, J. D., Ciccarelli, R. B., Higgins, T. J., Weiner, D. B. (1999). In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2 Mouse Model. J. Virol. 73: 501-509 [Abstract] [Full Text]  
• Milligan, G. N., Bernstein, D. I., Bourne, N. (1998). T Lymphocytes Are Required for Protection of the Vaginal Mucosae and Sensory Ganglia of Immune Mice Against Reinfection with Herpes Simplex Virus Type 2. J. Immunol. 160: 6093-6100 [Abstract] [Full Text]  
• Parr, M. B., Parr, E. L. (1998). Mucosal Immunity to Herpes Simplex Virus Type 2 Infection in the Mouse Vagina Is Impaired by In Vivo Depletion of T Lymphocytes. J. Virol. 72: 2677-2685 [Abstract] [Full Text]